Get the Stockscreener App
1.55
2.52%
-0.04
After Hours:
1.57
0.02
+1.29%
Vivani Medical Inc stock is traded at $1.55, with a volume of 135.11K.
It is down -2.52% in the last 24 hours and up +34.78% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.59
Open:
$1.6
24h Volume:
135.11K
Relative Volume:
1.32
Market Cap:
$91.83M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-3.1633
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
+10.71%
1M Performance:
+34.78%
6M Performance:
+29.17%
1Y Performance:
+19.23%
1-Day Range:
$1.52
$1.60
1-Week Range:
$1.38
$1.80
52-Week Range:
$0.9054
$1.80
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.55 | 82.94M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Stock (VANI) Latest News
What analysts say about Vivani Medical Inc. stockRapid portfolio appreciation - PrintWeekIndia
What drives Vivani Medical Inc. stock priceRapid growth opportunities - Autocar Professional
Is Vivani Medical Inc. a good long term investmentBreakout portfolio performance - Jammu Links News
Why Vivani Medical Inc. stock is on top investor watchlistsConsistent Win Signals - beatles.ru
Vivani Medical Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Will Vivani Medical Inc. stock split in the near futureFree Expert-Led Investment Training - Newser
3 Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance
How Vivani Medical Inc. stock performs during market volatilitySecure Growth Trading Plan - Newser
What makes Vivani Medical Inc. stock price move sharplyReliable High Profit Alerts - Newser
Why Vivani Medical Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
Vivani Medical (NASDAQ:VANI) Shares Down 2.3%Here's What Happened - MarketBeat
Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings - Yahoo Finance
Vivani Medical Holds 2025 Annual Stockholders Meeting - TipRanks
Vivani Medical (VANI) Appoints New CFO as Brigid Makes Retires | - GuruFocus
Sector Update: Health Care - MarketScreener
# Vivani Medical appoints Anthony Baldor as new CFO By Investing.com - Investing.com South Africa
Vivani Medical Appoints New CFO Amid Leadership Change - TipRanks
# Vivani Medical appoints Anthony Baldor as new CFO - Investing.com
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer - GlobeNewswire
Vivani Medical, Inc. Announces CFO Changes - MarketScreener
Vivani Medical to Present at the 2025 BIO International Convention - The Manila Times
Jane Street Group LLC Acquires Shares of 57,159 Vivani Medical, Inc. (NASDAQ:VANI) - Defense World
Vivani Medical, Inc. (NASDAQ:VANI) Shares Purchased by Northern Trust Corp - Defense World
Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - MSN
Companies To Watch: Vivani Medical - Life Science Leader
Vivani Medical spins off Cortigent as independent company By Investing.com - Investing.com South Africa
Vivani Medical Announces Spin-Off of Cortigent Subsidiary - TipRanks
Vivani Medical spins off Cortigent as independent company - Investing.com
Vivani (VANI) Plans to Spin Off Cortigent as an Independent Nasdaq Company | VANI Stock News - GuruFocus
Vivani Medical Announces Planned Spin-Off of Cortigent, Inc. as Independent Nasdaq Company in 2025 - Nasdaq
Vivani Medical Announces Filing of Form 10 Registration - GlobeNewswire
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders - Yahoo Finance
Brokers Issue Forecasts for Vivani Medical Q1 Earnings - MarketBeat
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars - MSN
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):